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INTRODUCTION
The healing of skin wounds is a dynamic and interactive process mediated by soluble factors, various cell types, and extracellular matrix. Reepithelialization begins at an early stage of wound healing and is associated with the removal of clotted blood and damaged stroma from the wound space (Singer and Clark, 1999) . During reepithelialization, epidermal cells undergo a marked phenotypic change compatible with cell movement. Various growth factors and cytokines, in addition to cell-cell and cell-matrix interactions, contribute to this step (Werner and Grose, 2003) .
Angiotensin II is a bioactive octapeptide that regulates blood pressure as well as salt and water homeostasis as a circulating hormone. Evidence also indicates that angiotensin II exerts paracrine or autocrine actions that are important for diverse processes in a variety of tissues (Paul et al., 2006) . A local renin-angiotensin system has been thought to operate in human skin (Steckelings et al., 2004; Takeda et al., 2004) . The topical administration of angiotensin II was found to promote skin wound healing (Rodgers et al., 1997) . Up-regulation of proteins related to angiotensin II function has also been detected at wound sites (Steckelings et al., 2005; Viswanathan and Saavedra, 1992) , indicative of a role for endogenous angiotensin II in the wound healing process. Furthermore, skin wound healing was found to be delayed in mice deficient in the angiotensin II type 1a receptor (Kurosaka et al., 2009; Yahata et al., 2006) .
Together, these findings implicate angiotensin II in skin homeostasis and wound healing. Indeed, angiotensin II has been shown to promote the migration of keratinocytes (Takeda et al., 2004; Yahata et al., 2006) , although the mechanism of this action has remained unclear.
Angiotensin II exerts its actions through type 1 (AT 1 R) and type 2 (AT 2 R) receptors, both of which are proteins with seven transmembrane domains. AT 1 R activates G protein-or This article has not been copyedited and formatted. The final version may differ from this version. scaffold that regulates a large network of signaling pathways (Shenoy and Lefkowitz, 2011) .
Certain AT 1 R ligands are "biased" in that they selectively activate β -arrestin-dependent ]angiotensin II is one such biased agonist for AT 1 R that does not activate the G protein-dependent signaling pathway (Holloway et al., 2002) . In contrast to AT 1 R, little is known of the biological functions of AT 2 R, although the receptor has been found to be expressed in epidermal cells and wound regions (Steckelings et al., 2005; Steckelings et al., 2004; Takeda et al., 2004; Viswanathan and Saavedra, 1992) .
To provide insight into the regulation of skin homeostasis and wound healing by angiotensin II, we have now investigated the mechanism by which angiotensin II promotes human keratinocyte migration. We analyzed cell migration with both the scrape-wound epithelial cell culture assay (scratch assay) and a single-cell migration assay based on time-lapse video microscopy. We found that both β -arrestin-dependent signaling downstream of AT 1 R and signaling from AT 2 R are necessary for angiotensin II-induced migration of keratinocytes. The activation of these signaling pathways induced generation of the active form of transforming growth factor-β (TGF-β), resulting in activation of the TGF-β receptor, which in turn mediated trans-activation of the epidermal growth factor (EGF) receptor in a ligand-independent manner.
This article has not been copyedited and formatted. The final version may differ from this version. 
Scratch assay
The assay was performed as described previously (Matsuura et al., 2007) but with some modifications. Confluent HaCat cell monolayers were incubated in serum-free DMEM for 12 h, scratched with the use of a 200-µl pipette tip, washed extensively, and cultured for 12 h in DMEM containing various concentrations of angiotensin II. The migration of cells into the wound area was evaluated. A similar assay was also performed with NHEKs cultured in HuMedia-KB2 medium (Kurabo), which does not contain growth supplements.
Single-cell migration assay
HaCat cells were cultured in serum-free DMEM for 8 h, after which the cells were isolated with trypsin-EDTA and transferred to 3.5-cm dishes at a density of 5 × 10 4 cells per dish in serum-free DMEM. The cells were incubated for 4 h and then exposed to various concentrations of angiotensin II and photographed every 2 min for 1 h with the use of an Axiovert S 100 inverted microscope equipped with a CO 2 incubation system (CZI-3) and a heated stage (Carl Zeiss, Jena, 
Immunoblot analysis
Cells were lysed in a solution containing 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% SDS, and a protease inhibitor cocktail (Roche Diagnostics, Tokyo, Japan). Equal amounts of cell lysate protein were subjected to SDS-polyacrylamide gel electrophoresis, and the separated proteins were transferred to a polyvinylidene difluoride membrane. The membrane was incubated first with antibodies to β -arrestin1/2 or to α -tubulin and then with horseradish peroxidase-conjugated secondary antibodies (Promega, Madison, WI). Immune complexes were detected with the use of a Chemi-Lumi One L detection kit (Nacalai Tesque, Kyoto, Japan) and Amersham Hyperfilm ECL (GE Healthcare/Amersham Biosciences, Piscataway, NJ).
RT-PCR analysis
Total RNA was extracted from HaCat cells or NHEKs with the use of an SV Total RNA Isolation This article has not been copyedited and formatted. The final version may differ from this version. and 5'-GACGCTGGCTGAAGCAATCTT-3' for AT 1 R, 5'-ACTTCGGGCTTGTGAACATC-3'
and 5'-TAAATCAGCCACAGCGAGGT-3' for AT 2 R, and 5'-ACCACAGTCCATGCCATCAC-3' and 5'-TCCACCACCCTGTTGCTGTA-3' for glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Assay of TGF-β1
Subconfluent HaCat cells in 3.5-cm culture dishes were cultured in serum-free DMEM for 4h or 12 h and then exposed to 30 nM angiotensin II also in serum-free DMEM for 1h or 12 h, respectively. The culture supernatants were then collected, concentrated 10-fold by lyophilization, and assayed for TGF-β1 with the use of a quantitative enzyme-linked immunosorbent assay (Quantikine ELISA kit, R&D Systems).
Analysis of EGF receptor phosphorylation
HaCat cells were washed twice with ice-cold phosphate-buffered saline and then lysed in a solution containing 150 mM NaCl, 25 mM Tris-HCl (pH 7.4), 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 2 mM EDTA, and both phosphatase and protease inhibitor cocktails 
Statistical analysis
Data are presented as means ± SEM and were compared between two groups with Student's t test and among three or more groups with one way ANOVA followed by post hoc Tukey-Kramer test. A P value of < 0.05 was considered statistically significant.
RESULTS
Angiotensin II-induced migration of keratinocytes
We examined the effect of angiotensin II on skin epithelial cell migration in vitro with the use of the scrape-wound epithelial cell culture (scratch) assay and a single-cell migration assay based on time-lapse video microscopy. These assays revealed that angiotensin II not only promoted the collective migration of the human keratinocyte cell line HaCat and normal human epidermal keratinocytes (NHEKs) but also increased the motility of individual cells in a concentration-dependent manner ( Fig. 1 ). The median effective concentration (EC 50 ) for angiotensin II determined by the two assays was 0.40 and 0.25 nM, respectively, for HaCat cells, and 1.34 and 0.85 nM, respectively, for NHEKs.
Roles of AT 1 R and AT 2 R in angiotensin II-induced keratinocyte migration
To investigate the signaling mechanism responsible for the promotion of cell migration by angiotensin II, we first examined the expression of angiotensin receptors in HaCat cells and
NHEKs. The expression of both AT 1 R and AT 2 R genes in these cells was revealed by reverse transcription (RT) and polymerase chain reaction (PCR) analysis ( Fig II on HaCat cell migration was also blocked by candesartan and by PD123319 (Fig. 3B) . In contrast, CGP42112, a specific ligand for AT 2 R but not for AT 1 R, did not promote the migration of HaCat cells at concentrations up to 1 µM (Fig. 3A) . Given that the K d value of CGP42112 for AT 2 R is in the nanomolar range (Bosnyak et al., 2011) , these results suggested that the effect of angiotensin II on cell migration might require activation of AT 1 R in addition to that of AT 2 R. To confirm further the roles of both AT 1 R and AT 2 R in angiotensin II-induced cell migration, we depleted HaCat cells of these receptors by RNA interference (RNAi) with two different small interfering RNAs (siRNAs) for each receptor (Fig. 3C ). Angiotensin II did not promote the migration of the AT 1 R-or AT 2 R-depleted cells in the single-cell migration assay (Fig. 3D ).
Role of β -arrestin-dependent signaling in angiotensin II-induced keratinocyte migration
We next examined the effects of a biased agonist for AT 1 R (Miura and Karnik, 1999) and that it has a high affinity for AT 2 R (K d = 2 nM) (Miura and Karnik, 1999) , these results suggested that β -arrestin-dependent signaling from AT 1 R together with signaling from AT 2 R might be This article has not been copyedited and formatted. The final version may differ from this version. HaCat cell migration by angiotensin II in the single-cell migration assay, whereas it had no effect on the basal level of cell migration (Fig. 4D ).
TGF-β mediates angiotensin II-induced cell migration
Angiotensin II increases production of the active form of TGF-β in various cell types. We therefore next examined the effect of neutralizing antibodies to TGF-β on angiotensin II-induced
HaCat cell migration in the scratch assay. The antibodies completely inhibited the stimulatory effect of angiotensin II on cell migration (Fig. 5A ). An inhibitor of the TGF-β receptor, SB431542, also blocked angiotensin II-induced cell migration (Fig. 5A ). Essentially identical results were obtained with the single-cell migration assay (data not shown). Furthermore, TGF-β1 promoted HaCat cell migration in the scratch assay in a concentration-dependent manner (Fig. 5B ). This effect of TGF-β1 was not inhibited by candesartan or PD123319 (Fig.   5C ). When we measured the amounts of TGF-β1 in the culture medium of HaCat cells, TGF-β1 significantly increased in the medium of angiotensin II-treated cells at 1 h and 12 h after addition of angiotensin II (Fig. 5D ). We also found that this effect was inhibited by candesartan or PD123319 (Fig. 5D ). On the other hand, the amounts of TGF-β1 mRNAs in HaCat cells were not significantly affected by exposure of the cells to angiotensin II (Supplemental Fig. 1 ). These results thus suggested that activation of angiotensin II receptors induces generation of the active form of TGF-β without its transcription enhancement, and consequent activation of the TGF-β receptor in keratinocytes.
Role of the EGF receptor in angiotensin II-induced cell migration
We next explored signaling downstream of TGF-β in the promotion of HaCat cell migration by angiotensin II. Activation of the TGF-β receptor has previously been found to result in trans-activation of the EGF receptor in a ligand-dependent or -independent manner in HaCat cells (Joo et al., 2008; Koivisto et al., 2006) . We found that neutralizing antibodies to the EGF receptor abolished the effect of angiotensin II on HaCat cell migration in the scratch assay (Fig.   6A ). To determine whether activation of the EGF receptor induced by angiotensin II is ligand dependent, we examined the effects of neutralizing antibodies to EGF receptor ligands including amphiregulin, EGF, TGF-α, and heparin-binding EGF-like growth factor (HB-EGF) on angiotensin II-induced HaCat cell migration. None of these antibodies inhibited the effect of angiotensin II on cell migration (Fig. 6A ), although they all inhibited (at the concentration used in the migration assay) phosphorylation of the EGF receptor induced by the corresponding ligand (Supplemental Fig. 2 ). An inhibitor of HB-EGF, CRM197, also had no effect on angiotensin II-induced cell migration (Fig. 6A) , although it also inhibited HB-EGF-induced phosphorylation of the EGF receptor (Supplemental Fig. 2 ). The TGF-β-induced migration of HaCat cells was also abolished by neutralizing antibodies to the EGF receptor but not by those to HB-EGF or by CRM197 (Fig. 6B) . These results thus suggested that trans-activation of the EGF receptor induced by the TGF-β receptor downstream of angiotensin II in HaCat cells is ligand independent.
To confirm the signaling mechanism responsible for angiotensin II-induced cell migration, we monitored phosphorylation of the EGF receptor. The extent of EGF receptor phosphorylation in HaCat cells was increased 5 min after the addition of angiotensin II and remained increased at 30 min (Fig. 7A ). Candesartan and PD123319 each inhibited angiotensin II-induced This article has not been copyedited and formatted. The final version may differ from this version. phosphorylation of the EGF receptor (Fig. 7B, C) , as did RNAi-mediated depletion of β -arrestin2 (Fig. 7D) . Furthermore, the TGF-β receptor inhibitor SB431542 attenuated angiotensin II-induced phosphorylation of the EGF receptor (Fig. 7E) , whereas neutralizing antibodies to HB-EGF had no such effect (Fig. 7F) .
DISCUSSION
Among various actions of angiotensin II during skin wound healing, we focused on the promotion of keratinocyte migration and its underlying mechanism. We found that activation of both AT 1 R and AT 2 R is necessary for this effect of angiotensin II. Furthermore, our observations that a biased agonist for AT 1 R, [Sar 1 ,Ile 4 ,Ile 8 ]angiotensin II, also promoted cell migration and that angiotensin II-induced migration was inhibited by depletion of β -arrestin2 suggested that β -arrestin-dependent signaling by AT 1 R as well as signaling downstream of AT 2 R are responsible for the stimulatory effect of angiotensin II on keratinocyte migration. Our results further indicated that activation of both AT 1 R and AT 2 R in keratinocytes increased production of the active form of TGF-β, resulting in activation of the TGF-β receptor and consequent trans-activation of the EGF receptor in a ligand-independent manner. These angiotensin II-induced signaling pathways in keratinocytes were confirmed by monitoring phosphorylation of the EGF receptor. On the basis of these pharmacological, biochemical, and molecular biological observations, we propose a model for the mechanism of angiotensin II-induced migration of keratinocytes (Fig. 8) .
We showed that activation of both AT 1 R and AT 2 R is necessary for angiotensin II-induced Our examination of the effects of an AT 2 R-specific ligand and of AT 1 R depletion indicated that activation of AT 2 R alone is not sufficient for angiotensin II-induced keratinocyte migration.
Depletion of AT 2 R also revealed that AT 1 R alone is not sufficient for this effect of angiotensin II.
Given that AT 1 R and AT 2 R have been shown to form a heterodimeric complex (AbdAlla et al.,
2001), such direct interaction of the receptors might play an important role in signaling responsible for the promotion of cell migration by angiotensin II.
Angiotensin II has been shown to induce the release of TGF-β from various cell types-including vascular smooth muscle cells (Gibbons et al., 1992; Koibuchi et al., 1993) , renal proximal tubular cells (Wolf et al., 1993) , glomerular mesangial cells (Kagami et al., 1994) , cardiac fibroblasts and myofibroblasts (Campbell and Katwa, 1997; Fisher and Absher, 1995) , hypertrophy of renal proximal tubular cells (Chen et al., 2006) , growth of gastric cancer cells (Ebi et al., 2010) , and wound repair by airway epithelial cells (Ito et al., 2011) . TGF-β was also previously found to promote HaCat cell migration through trans-activation of the EGF receptor mediated by autocrine HB-EGF signaling (Koivisto et al., 2006) , whereas another study demonstrated ligand-independent trans-activation of the EGF receptor by TGF-β in these cells (Joo et al., 2008) . Furthermore, AT 1 R has been proposed to induce trans-activation of the EGF receptor through shedding of HB-EGF and thereby to promote migration of keratinocytes (Yahata et al., 2006) . Although the reason for these discrepancies is unclear, we have now shown that neither neutralizing antibodies to HB-EGF nor an inhibitor of HB-EGF (the diphtheria toxin mutant CRM197) had an effect on angiotensin II-or TGF-β-induced migration of HaCat cells or on angiotensin II-induced phosphorylation of the EGF receptor, indicating that angiotensin II promotes the migration of these cells in a manner dependent on EGF receptor activation but not on the shedding of HB-EGF. Consistent with those of a previous study (Joo et al., 2008) , our results thus suggest that TGF-β receptor-dependent trans-activation of the EGF receptor in a ligand-independent manner mediates the stimulatory effect of angiotensin II on keratinocyte migration.
In conclusion, our study suggests that β -arrestin-dependent signaling downstream of AT 1 R as well as AT 2 R signaling in keratinocytes induce production of the active form of TGF-β and consequent activation of the TGF-β receptor, which in turn induces trans-activation of the EGF receptor in a ligand-independent manner, and that this signaling cascade underlies the regulation of keratinocyte migration by angiotensin II. Elucidation of these signaling events responsible for angiotensin II-induced migration of keratinocytes sheds light on the molecular mechanisms of or for a total of 20 to 24 cells in two independent experiments (single-cell migration assay). ***P < 0.001. Migration data are means ± SEM for a total of 41 to 63 cells in four to six independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus corresponding control value or for the indicated comparisons. and the siRNAs for β -arrestin2 specifically depleted β -arrestin2 but not β -arrestin1. Migration data are means ± SEM for a total of 20 to 24 cells in two independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. angiotensin II, 1 µM candesartan, or 1 µM PD123319 for 1 h or 12 h, after which the amount of TGF-β1 in the culture supernatants was determined. Data are means ± SEM from five independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus corresponding control values or for the indicated comparisons. (50 µg/ml) or neutralizing antibodies to the EGF receptor (EGFR) (0.1 µg/ml), to amphiregulin (Amph) (50 µg/ml), to EGF (20 µg/ml), to TGF-α (10 µg/ml), or to HB-EGF (20 µg/ml). (B)
The scratch assay was performed in the presence of TGF-β1 (5 ng/ml) and with or without CRM197 (50 µg/ml) or neutralizing antibodies to the EGF receptor (0.1 µg/ml) or to HB-EGF (20 µg/ml). All data are means ± SEM from six independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. min, after which cell lysates were subjected to immunoprecipitation and immunoblot analysis (upper panel) as in (A). The normalized abundance of the phosphorylated EGF receptor (lower panel) was also determined as means ± SEM from 11 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. 
